Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Deferred Tax Liability: 2011-2024

Historic Non-Current Deferred Tax Liability for Lifecore Biomedical (LFCR) over the last 14 years, with May 2024 value amounting to $543,000.

  • Lifecore Biomedical's Non-Current Deferred Tax Liability rose 32.69% to $552,000 in Q4 2024 from the same period last year, while for Nov 2024 it was $552,000, marking a year-over-year increase of 32.69%. This contributed to the annual value of $543,000 for FY2024, which is 96.19% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Non-Current Deferred Tax Liability of $543,000 as of FY2024, which was down 96.19% from $14.2 million recorded in FY2023.
  • In the past 5 years, Lifecore Biomedical's Non-Current Deferred Tax Liability ranged from a high of $41.0 million in FY2020 and a low of $543,000 during FY2024.
  • Over the past 3 years, Lifecore Biomedical's median Non-Current Deferred Tax Liability value was $10.7 million (recorded in 2022), while the average stood at $8.5 million.
  • Per our database at Business Quant, Lifecore Biomedical's Non-Current Deferred Tax Liability spiked by 33.40% in 2023 and then plummeted by 96.19% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Non-Current Deferred Tax Liability (Yearly) stood at $41.0 million in 2020, then decreased by 11.14% to $36.5 million in 2021, then slumped by 70.74% to $10.7 million in 2022, then spiked by 33.40% to $14.2 million in 2023, then plummeted by 96.19% to $543,000 in 2024.